A TP is the primary utilizable source of high-energy phosphate bonds within the cell and acts as an allosteric effector of numerous cell processes. Most intracellular ATP is derived from cytosolic glycolysis and mitochondrial oxidative phosphorylation. The latter process couples the oxidation of reduced cofactors via the respiratory chain to ATP synthesis by mitochondrial ATP synthase. The supply of reduced cofactors (NADH, FADH 2 ) is ensured by mitochondrial oxidation of substrates derived from glucose, fatty acids, and amino acids via different metabolic pathways. Therefore, oxidative phosphorylation is a complex process regulated at different levels by the interactions of mitochondrial and cytosolic metabolism (1). In this crosstalk, mitochondrial Ca 2ϩ homeostasis, a process that has attracted a large interest in the past few years (2-11), appears to play a major role. Indeed, three dehydrogenases of the Krebs cycle (pyruvate, isocitrate, and ␣-ketoglutarate dehydrogenase) are modulated by [Ca 2ϩ ] in the micromolar range (12, 13). Recently, it has been shown that, despite the low affinity of the mitochondrial Ca 2ϩ uptake systems, large increases in matrix [Ca 2ϩ ] parallel the cytosolic Ca 2ϩ signals, thanks to the close contact between mitochondria and the intracellular Ca 2ϩ stores (14). The final outcome of this Ca 2ϩ transfer is expected to be the enhancement of mitochondrial ATP production to balance the increased ATP demand of a stimulated cell (15) (16) (17) (18) .
A
TP is the primary utilizable source of high-energy phosphate bonds within the cell and acts as an allosteric effector of numerous cell processes. Most intracellular ATP is derived from cytosolic glycolysis and mitochondrial oxidative phosphorylation. The latter process couples the oxidation of reduced cofactors via the respiratory chain to ATP synthesis by mitochondrial ATP synthase. The supply of reduced cofactors (NADH, FADH 2 ) is ensured by mitochondrial oxidation of substrates derived from glucose, fatty acids, and amino acids via different metabolic pathways. Therefore, oxidative phosphorylation is a complex process regulated at different levels by the interactions of mitochondrial and cytosolic metabolism (1) . In this crosstalk, mitochondrial Ca 2ϩ homeostasis, a process that has attracted a large interest in the past few years (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) , appears to play a major role. Indeed, three dehydrogenases of the Krebs cycle (pyruvate, isocitrate, and ␣-ketoglutarate dehydrogenase) are modulated by [Ca 2ϩ ] in the micromolar range (12, 13) . Recently, it has been shown that, despite the low affinity of the mitochondrial Ca 2ϩ uptake systems, large increases in matrix [Ca 2ϩ ] parallel the cytosolic Ca 2ϩ signals, thanks to the close contact between mitochondria and the intracellular Ca 2ϩ stores (14) . The final outcome of this Ca 2ϩ transfer is expected to be the enhancement of mitochondrial ATP production to balance the increased ATP demand of a stimulated cell (15) (16) (17) (18) .
In this paper, we directly addressed these issues by investigating, in intact living cells, the effect of cytosolic and mitochondrial Ca 2ϩ signaling on intramitochondrial ATP concentration. For this purpose, we have utilized a targeted recombinant Ca 2ϩ probe (mitochondrial aequorin, mtAEQ) (2) and constructed a tool, a specifically targeted chimera of the ATP-sensitive photoprotein luciferase, with the aim of dynamically monitoring the ATP concentration in the mitochondrial matrix ([ATP] m ). The basis for this approach to the measurement of this key cellular parameter was the observation that the affinity of luciferase for ATP, which in vitro is in the micromolar range, is drastically lower in vivo, presumably because of the presence of competing proteins and anions (19) . Indeed, in the cellular environment and in the presence of luciferin, luciferase light emission is a linear function of [ATP] in a concentration range between 10 Ϫ3 and 10 Ϫ2 M, i.e., in the physiological range (20, 21) . We thus constructed a chimeric cDNA, which allows the selective targeting of luciferase to the mitochondrial matrix. With this tool, we could not only directly demonstrate that agonist-dependent changes in mitochondrial Ca 2ϩ concentration correlate with an enhancement in mitochondrial ATP concentration, provided that oxidizable substrates are available, but also identify a phenomenon of long-term memory, allowing a prolonged metabolic ''priming'' that lasts longer than the mitochondrial [Ca 2ϩ ] increase. These observations may clarify how mitochondria can face the increased energy demand imposed by both short-term (e.g., secretion or contraction) and long-term (e.g., activation of gene transcription) effects of agonists acting by means of a rise in cytoplasmic Ca 2ϩ concentration.
Methods
Plasmid Construction. Cytosolic (untargeted) firefly luciferase was transferred from the plasmid pGL3 basic (Promega) to the plasmid pcDNA3 (Invitrogen) as an 876-nt BglII-HindIII fragment and then transferred to VR1012.
For the preparation of mitochondrial luciferase (mtLuc), DNA sequences encoding a mitochondrial presequence and the hemagglutinin HA1 tag were added to the luciferase cDNA as follows. A fragment of the luciferase cDNA was first amplified using the following primer: 5Ј-AAAGCTT AAT GGA AGA CGC CAA AAA CAT AAA GAA A (corresponding to the sequence encoding amino acids 1-9 of luciferase; HindIII site underlined) and GAA GAT GTT GGG GTG TTG TAA CAA T (spanning the endogenous ClaI site of the luciferase cDNA and encoding amino acids 456-465). The PCR product was digested with the enzymes HindIII and ClaI and fused in frame to the ClaI͞HindIII fragment encoding the HA1 tag (14) . A ClaI fragment was thus generated, which, in an appropriately prepared pBluescript SK(ϩ) plasmid, could be fused in frame with the EcoRI͞HindIII fragment encoding the N-terminal 33 aa of COX8 (25 aa of the cleavable presequence ϩ 8 aa of the mature polypeptide) (2) and the ClaI͞SalI fragment encoding the C-terminal portion of luciferase (amino acids 457-556). The whole final construct (denominated mtLuc, and shown schematically in Fig. 1 ) was excised by a NotI͞XhoI or PstI͞SalI digestion and cloned, respectively, into the expression vectors pcDNAI and VR1012. Cell Culture and Transfection. HeLa cells were grown in 1 g͞liter glucose DMEM, supplemented with 10% FCS. This concentration of glucose was chosen to decrease the dependency of these cells on glycolysis and increase their oxidative capacity. Cells were seeded for transfection onto 13-mm coverslips and grown to 50% confluence. Primary cultures of skeletal myotubes were prepared from newborn rats as previously described (22) , and myotubes were transfected on the second day of culture. Transfection with cytosolic luciferase (cytLuc) or mtLuc cDNA (4 g͞ml) was carried out according to a standard calciumphosphate procedure (14) . Measurements were performed either 36 hr after transfection or at day 7 of culture for HeLa cells and myotubes, respectively.
Luminescence Measurements. Cell luminescence was measured in a luminometer as previously described (14) . Cells (200,000-300,000 per coverslip) were constantly perfused with a modified Krebs-Ringer buffer containing: 125 mM NaCl, 5 mM KCl, 1 mM Na 3 PO 4 , 1 mM MgSO 4 , 1 mM CaCl 2 , 20 M luciferin, and 20 mM Hepes (pH 7.4 at 37°C) supplemented with either 5.5 mM glucose or 0.1 mM pyruvate͞1 mM lactate, as specified in the text. Complete equilibration in the chamber with new medium was obtained in 5 s. Under these conditions, the light output of a coverslip of transfected cells was in the range of 1,000-10,000 cps for each luciferase construct vs. a background lower than 10 cps. Luminescence was entirely dependent on the presence of luciferin and was proportional to the perfused luciferin concentration between 20 and 200 M. Agonists and inhibitors were tested for nonspecific effects on the luminescence of the non-ATP-utilizing luciferase of Renilla reniformis expressed in cytosol (23) . None were observed. When measured, mitochondrial Ca 2ϩ concentration ([Ca 2ϩ ] m ) was monitored in cells transiently transfected with mtAEQ, and calibration of luminescence signal was performed as previously described (14).
Immunocytochemistry. Cells were fixed and permeabilized 36 hr after transfection using 4% formaldehyde for 30 min and then 0.5% Triton X-100 for 5 min. Cells were then labeled with the anti-HA1 mAb 12CA5 and a rabbit anti-mouse secondary Ab conjugated to FITC, as previously described (14) . After immunostaining, cells were imaged with a Zeiss Axiovert inverted microscope.
Results and Discussion
Agonist-Triggered Mitochondrial and Cytosolic ATP Changes. To obtain mitochondrially targeted HA1-tagged luciferase, we fused the photoprotein to the targeting information of a mitochondrial protein, subunit VIII of cytochrome c oxidase. To this end, the sequences encoding firefly luciferase (24), HA1 tag, and COX8 (14) , were fused in frame, as specified in Materials and Methods. The final chimeric cDNA, mtLuc, encoded from the N to the C terminus: the 25-aa presequence and the first 8 aa of COX8 mature protein, the 9-aa HA1 epitope tag, and the whole photoprotein. When expressed in HeLa cells, the chimera was properly sorted to the mitochondria, as evident from the immunolocalization presented in Fig. 1 . Conversely, as previously observed (21, 23, 25) , in the absence of the targeting sequence, luciferase was retained in the cytoplasm.
By using both luciferase constructs, we dynamically monitored the effect of agonist- (Fig. 2B ). In the presence of 2-deoxyglucose, we thus observed a clear sensitivity to oligomycin, which causes a further decrease in the ATP content, first in the mitochondria ([ATP] m : to 13 Ϯ 4% of the initial value, n ϭ 5) and then in the cytosol ([ATP] c : to 26 Ϯ 6% of the initial value, n ϭ 5) (Fig. 2B) . These latter results indicate that, in HeLa cells, mitochondrial ATP synthesis is recruited only when the glycolytic pathway is impaired.
To increase the contribution of mitochondrial ATP synthesis to cellular ATP homeostasis, we perfused HeLa cells with the mitochondrial substrate pyruvate (0.1 mM) in the absence of glucose; lactate (1 mM) was also included to maintain intracellular NADH levels. Under these conditions, when HeLa cells were challenged with histamine, there was a marked increase of both [ATP] c (peak value: 130 Ϯ 12%, n ϭ 30) and [ATP] m (peak value: 160 Ϯ 30%, n ϭ 30) (Fig. 2C) . Pretreatment of the cells with oligomycin (5 M, 5 min) abolished the agonist-induced increases in [ATP] m (107 Ϯ 4% of the prestimulatory value, n ϭ 10) and in [ATP] c (95 Ϯ 5% of the prestimulatory value, n ϭ 10) (Fig. 2D) , indicating that they are the results of mitochondrial ATP synthesis. As noticed in other cell types (28), we also observed a stable rise in ⌬⌿ m after agonist stimulation (Fig. 2E) . This suggests that the increase in [ATP] m reflects long-lasting elevation of the mitochondrial energy state.
To verify whether the agonist-dependent changes in [ATP] m observed in HeLa cells were a general phenomenon, we carried out similar experiments in other cell types. In particular, we show here those obtained in primary cultures of skeletal myotubes. These cells differ substantially from HeLa cells in their embryological origin, Ca 2ϩ signaling patterns, and mechanisms (29, 30) and are expected to display less glycolytic behavior. Indeed, when myotubes were depolarized by perfusing a high K ϩ saline solution, and thus a Ca 2ϩ signal was elicited via the opening of both plasma membrane and endoplasmic reticulum Ca 2ϩ channels (22) , a major increase in [ATP] m was also observed in the presence of glucose (Fig. 3A) . Accordingly, when atractyloside, which blocks the mitochondrial ATP͞ADP exchanger, was applied to myotubes (40 M, 5 min), we observed a significant decrease in [ATP] c , not only when cells were perfused with pyruvate and lactate, but also when glucose was the metabolic substrate ([ATP] c : to 62 Ϯ 5% and 77 Ϯ 3% of the initial value, respectively, n ϭ 5). This result indicates that, in myotubes, in contrast to HeLa cells, mitochondrial oxidative metabolism contributes significantly to cellular ATP homeostasis in growth medium containing glucose. However, as for HeLa cells, the agonist-triggered rises in [ATP] m are more substantial when cells are perfused with pyruvate and lactate (peak maximum ϭ 163 Ϯ 21%, n ϭ 10) (Fig. 3B) . Pretreatment of the myotubes with atractyloside reduced the agonist-induced increase in [ATP] m , yielding a peak of only 110 Ϯ 2% above basal (n ϭ 5), while not noticeably modifying resting levels of [ATP] m (Fig. 3C) . Taken together, the results obtained in HeLa cells and myotubes allow us to conclude that agonist-induced Ca 2ϩ signals are able to trigger [ATP] m rises, the kinetics and the final value of which are dependent on both cell metabolism and substrate supply to mitochondria. , supplemented with 1 mM EGTA and pyruvate and lactate as metabolic substrate, as specified above) before carrying out the histamine stimulation. By this procedure, the histaminetriggered [Ca 2ϩ ] m rise could be progressively decreased (Fig. 4A,  traces b-d (Fig. 4A) . This sigmoidal behavior is illustrated in Fig. 4B . Taken Fig. 2 A and 2C) . It can thus be concluded that, together with the amplitude of the [Ca 2ϩ ] rise in the mitochondrial matrix, the availability of mitochondrial substrates is a key determinant in the capacity of mitochondria to activate ATP production upon cell stimulation.
Evidence for a Mitochondrial Memory Mechanism. Ca 2ϩ signals are frequently transient in nature, but often give rise to many long-lasting functional consequences in stimulated cells (17, 32, 33) . To investigate how mitochondria can meet a persistent increase in cellular energy demand, we studied whether the information conveyed by Ca 2ϩ signals is stored by mitochondria, even after a return of [Ca 2ϩ ] m to basal levels. If this were the case, one may predict that, even if mitochondrial ATP synthesis is not recruited at the time of the agonist challenge, mitochondria may retain a memory of the Ca 2ϩ stimulation. To test this hypothesis, we took advantage of the dichotomy of HeLa cell metabolism. When glucose was replaced with pyruvate and lactate in the perfusion medium, a transient increase in both [ATP] m (113 Ϯ 3% above basal, n ϭ 5) and [ATP] c (112 Ϯ 2% above basal, n ϭ 5) (Fig. 5A ) was observed. When cells were previously exposed to histamine, the rise produced by the subsequent perfusion with mitochondrial substrates was dramatically enhanced. This result is illustrated in Fig. 5B . A cytosolic, and hence mitochondrial, Ca 2ϩ signal was triggered by applying histamine to HeLa cells perfused with glucose. Then, after agonist wash-out, glucose was replaced with pyruvate and lac- . This long-term activation was still observed, with similar amplitude and kinetics, 30 min after agonist stimulation but decreased rapidly after 1 hr (Fig. 5C) . Therefore, mitochondria retain a memory of Ca 2ϩ -signaling information, which does not involve a sustained [Ca 2ϩ ] m rise (see Fig. 5B , trace c), allowing them to match an increased ATP demand with an enhanced ATP synthesis. This memory mechanism may involve stable, metabolite-dependent increases in pyruvate dehydrogenase activity, as described recently in hepatocytes (28), or reflect a persistent Ca 2ϩ -triggered activation of the respiratory chain (28, 34) . Given the prolonged time course of this phenomenon, an alternative possibility would be a Ca 2ϩ -dependent activation or deinhibition of one of the steps of oxidative phosphorylation, e.g., an unknown regulatory molecule achieving a long-lasting Ca 2ϩ -dependent conformational change. In heart mitochondria, an ATP synthase inhibitory factor, termed calcium binding inhibitor (35) , has been described to dissociate into monomers upon Ca 2ϩ binding, leading to an activation of the ATP synthase. However, little is know about its action in vivo and specifically about its kinetics of reassociation with the ATP synthase. Other possibilities include a change in mitochondrial volume, leading to activation of the respiratory chain (34) , or other changes in mitochondrial morphology. overload. Moreover, it may allow mitochondrial control over ATP-regulated cell processes, such as ion channel activity or secretion (21) , providing an example of how temporally controlled Ca 2ϩ signals may be decoded (32, 33) into prolonged effects inside the cell.
Conclusions

